Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells.
Open Access
- 1 February 1995
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 95 (2) , 555-563
- https://doi.org/10.1172/jci117698
Abstract
We have explored the mechanism(s) related to FIAU-induced liver toxicity, particularly focusing on its effect on mitochondrial function in a human hepatoma cell line-HepG2. The potential role of FMAU and FAU, metabolites detected in FIAU-treated patients were also ascertained. FIAU and FMAU inhibited cell growth and were effectively phosphorylated. A substantial increase in lactic acid production in medium of cells incubated with 1-10 microM FIAU or FMAU was consistent with mitochondrial dysfunction. Slot blot analysis demonstrated that a two week exposure to 10 microM FIAU or FMAU was not associated with a decrease in total mitochondrial (mt) DNA content. However, FIAU and FMAU were incorporated into nuclear and mtDNA and relative values suggest that both compounds incorporate at a much higher rate into mtDNA. Electron micrographs of cells incubated with 10 microM FIAU or FMAU revealed the presence of enlarged mitochondria with higher cristae density and lipid vesicles. In conclusion, these data suggest that despite the lack of inhibition of mtDNA content, incorporation of FIAU and FMAU into mtDNA of HepG2 cells leads to marked mitochondrial dysfunction as evidenced by disturbance in cellular energy metabolism and detection of micro- and macrovesicular steatosis.Keywords
This publication has 32 references indexed in Scilit:
- The in vitro anti-hepatitis B virus activity of FIAU [1-(2′-deoxy-2′-fluoro-1-β-d-arabinofuranosyl-5-iodo)uracil] is selective, reversible, and determined, at least in part, by the host cellAntiviral Research, 1994
- Nucleoside Analogs: Similarities and DifferencesClinical Infectious Diseases, 1993
- DidanosineDrugs, 1992
- Adaptation of Mitochondrial Metabolism in Liver Cirrhosis: Different Strategies to Maintain a Vital FunctionScandinavian Journal of Gastroenterology, 1992
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Comparison of the effect of Carbovir, AZT, and dideoxynucleoside triphosphates on the activity of human immunodeficiency virus reverse transcriptase and selected human polymerasesBiochemical and Biophysical Research Communications, 1989
- Chronic type B hepatitis and the “healthy” Hbsag carrier stateHepatology, 1987
- Drug metabolism by the human hepatoma cell, Hep G2Biochemical and Biophysical Research Communications, 1987
- Sequence and organization of the human mitochondrial genomeNature, 1981
- Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell lineNature, 1979